Guided Therapeutics (GTHP) Total Debt (QoQ) (2011 - 2025)
Guided Therapeutics (GTHP) Total Debt (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.69% |
| Sep 30, 2025 | -17.14% |
| Jun 30, 2025 | -14.63% |
| Mar 31, 2025 | -12.77% |
| Dec 31, 2024 | -96.03% |
| Sep 30, 2024 | -0.50% |
| Jun 30, 2024 | 4,853.55% |
| Sep 30, 2023 | -83.28% |
| Jun 30, 2023 | 2,372.55% |
| Mar 31, 2023 | -69.05% |
| Dec 31, 2022 | -93.23% |
| Sep 30, 2022 | 1,321.62% |
| Jun 30, 2022 | 183.19% |
| Mar 31, 2022 | -96.03% |
| Dec 31, 2021 | -15.53% |
| Sep 30, 2021 | -9.24% |
| Jun 30, 2021 | 43.53% |
| Mar 31, 2021 | 75.57% |
| Dec 31, 2020 | 604.00% |
| Sep 30, 2020 | -91.44% |